Tag: futurism

Posts with tag: futurism

Latest Posts

Medtronic Q3 Profit Tops Estimates on Strong Device Demand

Medtronic beats quarterly profit estimates on strong device demand, but keeps annual forecast unchanged

Greek Shipyards Surge Back to Life

Greece's Skaramangas Shipyard rebounds from crisis, sees increased business in ship repairs.

Oil Steadies as Market Weighs Fallout From Trump's Tariff Order

Oil steadies as market weighs potential impact of Trump's trade tariffs, with Brent near $75 and WTI above $71.

Motorola Forecasts Strong Growth Amid Heightened Security Demand

Motorola Solutions forecasts Q1 adjusted profit above estimates driven by strong demand for safety and security services.

Hims & Hers Stock Jumps on Telehealth Weight-Loss Drug Controversy

Hims & Hers stock surges after Super Bowl ad promoting affordable weight-loss drugs sparks controversy and attracts attention from Congress and the new HHS secretary.

Arm to Launch Own Chip, Shift to Direct Manufacturing

Chip designer Arm is reportedly planning to release its first in-house chip this year, with Meta among its early customers.

The Stock Market is Jittery About Inflation

Deere's Quarterly Revenue Slumps 30%, Shares Drop

Deere's quarterly revenue plunges 30%, missing expectations as farmers opt to rent equipment amid weak incomes and high borrowing costs.

Trinseo Reports Q4 Loss of $117.9M

Trinseo PLC (TSE) reported a Q4 loss of $117.9 million ($3.33 per share). Adjusted for non-recurring costs, the loss was $2.67 per share. Revenue came in at $821.5 million. For the year, the company reported a loss of $348.5 million ($9.86 per share), with revenue of $3.51 billion.

CVS Beats Earnings Estimates, Sending Stock Higher

CVS (CVS) reported Q4 and FY24 earnings, beating estimates and sending shares up 8% pre-market. Revenue was $372.8B for the year and $97.7B for Q4, beating estimates of $96.8B. The healthcare benefits segment saw a slight decline due to Medicare and Medicaid headwinds, while the retail pharmaceutical and healthcare services segments increased. Despite a challenging year and ongoing government headwinds, CVS remains the largest PBM and provided 2025 guidance with adjusted EPS of $5.75-$6.00.